Clifton O. Bingham

发表

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

M. D. de Wit, D. M. van der Heijde, V. Bykerk, 2012, Annals of the rheumatic diseases.

2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases

A. Bass, J. Sparks, J. Reston, 2023, Arthritis care & research.

Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritis.

P. Gregersen, M. Jensen, W. Robinson, 2016, Annals of the rheumatic diseases.

Anti–Peptidylarginine Deiminase 4 Autoantibodies and Disease Duration as Predictors of Treatment Response in Rheumatoid Arthritis

E. Darrah, L. Cappelli, Clifton O. Bingham, 2023, ACR open rheumatology.

Combining online and in-person methods to evaluate the content validity of PROMIS fatigue short forms in rheumatoid arthritis

A. Orbai, V. Bykerk, C. Bingham, 2018, Quality of Life Research.

Three doses of COVID-19 mRNA vaccine induce class-switched antibody responses in inflammatory arthritis patients on immunomodulatory therapies

Venkata Gayatri Dhara, J. Blankson, A. Pekosz, 2023, Frontiers in immunology.

Conversion of Functional Assessment of Chronic Illness Therapy–Fatigue to Patient‐Reported Outcomes Measurement Information System Fatigue Scores in Two Phase III Baricitinib Rheumatoid Arthritis Trials

D. Cella, C. Bingham, S. Bartlett, 2020, Arthritis care & research.

OARSI/OMERACT Initiative to Define States of Severity and Indication for Joint Replacement in Hip and Knee Osteoarthritis. An OMERACT 10 Special Interest Group

M. Suarez‐Almazor, M. Dougados, J. Singh, 2011, The Journal of Rheumatology.

Enhanced Reactivity to Pain in Patients with Rheumatoid Arthritis Open Access Enhanced Reactivity to Pain in Patients with Rheumatoid Arthritis

J. Haythornthwaite, Ajay D. Wasan, Michael T. Smith, 2022 .

Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis Patients

E. Keystone, V. Bykerk, C. Hitchon, 2015, Arthritis care & research.

Patient‐reported outcomes

B. Shea, A. Lyddiatt, T. Devji, 2019, Cochrane Handbook for Systematic Reviews of Interventions.

Overview of benefit/risk of biological agents.

S. Abramson, C. Bingham, A. Imperato, 2004, Clinical and experimental rheumatology.

Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial.

C. Christiansen, J. Meyer, G. Cline, 2008, Osteoarthritis and cartilage.